Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Prostate cancer

How to manage prostate cancer with lymph node metastases?

Nature Reviews Urology volume 11, pages 137–138 (2014)Cite this article

Subjects

Few series have reported on the incidence of lymph node metastases, multimodal treatment, and long-term outcomes associated with extended pelvic lymph node dissection in large cohorts of patients with surgically treated prostate cancer. The first nomograms for predicting prognosis from such data have only recently been developed and internally validated.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Partin, W. A. et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 277, 1445–1451 (1997).

    Article  CAS  Google Scholar 

  2. Briganti, A. et al. Two positive nodes represent a significant cut-off value for cancer specific survival in patients with node positive prostate cancer. A new proposal based on a two-institution experience on 703 consecutive n+ patients treated with radical prostatectomy, extended pelvic lymph node dissection and adjuvant therapy. Eur. Urol. 55, 261–270 (2009).

    Article  Google Scholar 

  3. Abdollah, F. et al. Predicting survival of patients with node-positive prostate cancer following multimodal treatment. Eur. Urol. http://dx.doi.org/101016/j.eururo.213.09.025.

  4. Jeschke, S. et al. Laparoscopic radioisotope-guided sentinel lymph node dissection in staging of prostate cancer. Eur. Urol. 53, 126–132 (2008).

    Article  Google Scholar 

  5. Ward, J. F., Slezak, J. M., Blute, M. L., Bergstralh, E. J. & Zincke, H. Radical prostatectomy for clinically advanced (cT3) prostate cancer since advent of prostate-specific antigen testing: 15-year outcome. BJU Int. 95, 751–756 (2005).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Deptartment of Urology, Paracelsus Medical University, 48 Müllner Hauptstrasse, Salzburg, 5020, Austria

    Günter Janetschek & Stephan Hruby

Authors
  1. Günter Janetschek
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephan Hruby
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Günter Janetschek.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Janetschek, G., Hruby, S. How to manage prostate cancer with lymph node metastases?. Nat Rev Urol 11, 137–138 (2014). https://doi.org/10.1038/nrurol.2013.321

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2013.321

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing